文献速递心力衰竭与心肌病

补体与MAPK激活与SARS-CoV-2相关心肌炎症的关联

Association of Complement and MAPK Activation With SARS-CoV-2-Associated Myocardial Inflammation.
PubMed 文献 · JAMA Cardiol · 2022-01-01

该病例系列研究对比了5例SARS-CoV-2感染患者与免疫介导性心肌炎、非SARS-CoV-2病毒性心肌炎及非炎症性心肌病患者的终末期心肌活检标本。结果发现SARS-CoV-2感染心肌组织中CD163+巨噬细胞丰富而淋巴细胞较少,补体级联成分(C1q亚单位、SERPING1)及丝氨酸/苏氨酸MAPK通路上调。提示SARS-CoV-2相关心肌炎症具有独特的免疫特征。

要点

  • SARS-CoV-2感染心肌中CD163+巨噬细胞丰富,淋巴细胞低于其他心肌炎。
  • 补体C1q亚单位转录组增2.5-3.6倍、蛋白组增2.0-3.4倍。
  • 心脏巨噬细胞C1q丰度在SARS-CoV-2感染中最高,MAPK通路上调。

核心结论

  • SARS-CoV-2感染相关心肌炎症的免疫特征与其他病因心肌炎不同,表现为补体级联和MAPK通路激活。

研究设计与样本

  • 德国慕尼黑大学医院与图宾根大学心肌病理转诊中心的合作病例系列研究。
  • 纳入19例疑似心肌炎患者,其中心脏组织来自5例SARS-CoV-2感染住院患者(2020年3月至5月)。
  • 对照包括5例免疫介导性心肌炎、4例非SARS-CoV-2病毒性心肌炎和5例非炎症性心肌病(2019年1月至8月采集)。
  • 所有标本均经心内膜心肌活检,行免疫组化、RNA外显子捕获测序和质谱蛋白质组分析。

主要发现

  • 19例参与者中位年龄58岁(范围37-76岁),15例(79%)为男性。
  • 心肌炎患者心脏组织中CD163+巨噬细胞丰度普遍较高。
  • SARS-CoV-2感染患者心肌淋巴细胞计数低于非SARS-CoV-2病毒性和免疫介导性心肌炎患者。
  • SARS-CoV-2感染患者中补体级联成分C1q亚单位转录组增2.5-3.6倍、蛋白组增2.0-3.4倍。
  • 丝氨酸/半胱氨酸蛋白酶抑制剂G成员1转录组增1.7倍、蛋白组增2.6倍;心脏巨噬细胞C1q丰度在SARS-CoV-2感染中最高。

临床怎么用

  • 提示SARS-CoV-2感染相关心肌炎症可能存在补体及MAPK通路介导的独特免疫机制。
  • 未来需进一步研究这些免疫通路在心肌炎症中的作用。

局限性

  • 研究为小样本病例系列(SARS-CoV-2组仅5例),未收集种族和民族数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Myocardial injury is a common feature of patients with SARS-CoV-2 infection. However, the cardiac inflammatory processes associated with SARS-CoV-2 infection are not completely understood. OBJECTIVE: To investigate the inflammatory cardiac phenotype associated with SARS-CoV-2 infection compared with viral myocarditis, immune-mediated myocarditis, and noninflammatory cardiomyopathy by integrating histologic, transcriptomic, and proteomic profiling. DESIGN, SETTING, AND PARTICIPANTS: This case series was a cooperative study between the Ludwig Maximilian University Hospital Munich and the Cardiopathology Referral Center at the University of Tübingen in Germany. A cohort of 19 patients with suspected myocarditis was examined; of those, 5 patients were hospitalized with SARS-CoV-2 infection between March and May 2020. Cardiac tissue specimens from those 5 patients were compared with specimens from 5 patients with immune-mediated myocarditis, 4 patients with non-SARS-CoV-2 viral myocarditis, and 5 patients with noninflammatory cardiomyopathy, collected from January to August 2019. EXPOSURES: Endomyocardial biopsy. MAIN OUTCOMES AND MEASURES: The inflammatory cardiac phenotypes were measured by immunohistologic analysis, RNA exome capture sequencing, and mass spectrometry-based proteomic analysis of endomyocardial biopsy specimens. RESULTS: Among 19 participants, the median age was 58 years (range, 37-76 years), and 15 individuals (79%) were male. Data on race and ethnicity were not collected. The abundance of CD163+ macrophages was generally higher in the cardiac tissue of patients with myocarditis, whereas lymphocyte counts were lower in the tissue of patients with SARS-CoV-2 infection vs patients with non-SARS-CoV-2 virus-associated and immune-mediated myocarditis. Among those with SARS-CoV-2 infection, components of the complement cascade, including C1q subunits (transcriptomic analysis: 2.5-fold to 3.6-fold increase; proteomic analysis: 2.0-fold to 3.4-fold increase) and serine/cysteine proteinase inhibitor clade G member 1 (transcriptomic analysis: 1.7-fold increase; proteomic analysis: 2.6-fold increase), belonged to the most commonly upregulated transcripts and differentially abundant proteins. In cardiac macrophages, the abundance of C1q was highest in SARS-CoV-2 infection. Assessment of important signaling cascades identified an upregulation of the serine/threonine mitogen-activated protein kinase pathways. CONCLUSIONS AND RELEVANCE: This case series found that the cardiac immune signature varied in inflammatory conditions with different etiologic characteristics. Future studies are needed to examine the role of these immune pathways in myocardial inflammation.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Weckbach LT, Schweizer L, Kraechan A, et al. Association of Complement and MAPK Activation With SARS-CoV-2-Associated Myocardial Inflammation. JAMA Cardiol. 2022. PMID: 34910083. doi:10.1001/jamacardio.2021.5133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。